Building on Cyclotek’s original 2017 agreement with Duchembio Co. Ltd., Cyclotek now holds
read MoreCyclotek, Australia’s leading radiopharmaceutical CDMO, is proud to announce its successful
read MoreCyclotek is excited to announce a contract development and manufacturing agreement with Radio
read MoreCyclotek would like to extend our congratulations to the team at Spago Nanomedical AB on the
read MoreCyclotek is delighted to be a part of the Monash University-led study to investigate the safe
read MoreCyclotek and the University of Melbourne’s Bio21 Institute are pleased to announce a signif
read More
[contact-form-7 id=”714″ title=”Update Form”]
